ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors.

Jhanelle E Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.